Junshi Biosciences and Coherus Share Update on the FDA Review of the Biologics License Application (BLA) for Toripalimab as Treatment for Recurrent or Metastatic Nasopharyngeal Carcinoma (NPC)

– FDA has been unable to travel to China to conduct the required site inspection resulting in delayed action on the BLA – – Junshi Biosciences and Coherus are actively engaged in ongoing discussions with the FDA to support the inspections and gain approval of toripalimab for patients with NPC in the U.S. as quickly […]

Continue Reading

Some 14,057 inmates receive Christmas remission: ministry

The Ministry of Law and Human Rights granted 2022 Christmas Special Remission to 14,057 Christian and Catholic inmates across Indonesia to appreciate their good behavior. There are 19,728 Christian inmates across Indonesia, Public Relations and Protocol Coordinator at the Correctional Directorate General Rika Aprianti said in a statement on Saturday. From all these prisoners that had […]

Continue Reading